Partner & Co-Chair, Emerging Companies + Venture Capital Group
Jim Krenn has extensive experience representing private and public companies and investors in significant business transactions from formation through liquidity. His practice focuses on mergers and acquisitions, venture capital financings, and emerging company counseling for clients in a broad range of industries, including biopharmaceuticals, medical devices, artificial intelligence, and agtech.
Jim advises clients on private and public acquisitions on both the buy-side and sell-side across numerous transaction structures. He also counsels emerging and established life sciences and technology companies in equity financings and general corporate matters, and angel, corporate, and venture capital investors in investments in such companies. He has represented buyers and sellers in acquisitions and divestitures ranging from the low millions to over $1 billion as well as clients in over $2 billion in equity and debt financings ranging from seed rounds to $100 million-plus later-stage rounds. Jim serves on the Board of Directors of the San Diego Entrepreneurs Exchange.